Lactoferrin Protects against Development of Hepatitis Caused by Sensitization of Kupffer Cells by Lipopolysaccharide

BALB/c mice were intravenously injected with lipopolysaccharide (LPS) (0.05 μg/g of body weight) 7 days after being primed with zymosan. Recombinant human lactoferrin (250 μg/g of body weight), intravenously administered 1 day before the injection of LPS, significantly lessened the severity of hepat...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Yamaguchi, Makoto, Matsuura, Motoi, Kobayashi, Kiyoshi, Sasaki, Hajime, Yajima, Takaji, Kuwata, Tamotsu
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2001
Gaiak:
Immune-Mediated Responses and Disorders
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC96255/
https://ncbi.nlm.nih.gov/pubmed/11687469
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CDLI.8.6.1234-1239.2001
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak